Literature DB >> 8781311

Hepatitis B virus mutations in the pre-S genome before and after liver transplantation.

C Trautwein1, H Schrem, H L Tillmann, S Kubicka, D Walker, K H Böker, H J Maschek, R Pichlmayr, M P Manns.   

Abstract

Mutational changes in the pre-S region of hepatitis B virus (HBV) were analyzed in 20 patients who experienced HBV reinfection after orthotopic liver transplantation (OLT). HBV DNA was extracted from patient sera before and after OLT. The pre-S sequence was amplified via polymerase chain reaction, subcloned, sequenced, and analyzed. In 18 of 20 patients, mutational changes were found in the pre-S region pre- or post- OLT; 11 showed point mutations (1-10) and 7 cases major changes (insertions/deletions). For the point mutations, there was no trend in the selection of wild-type (wt) HBV before or after OLT in the pre-S region. Additional HBV reinfection during hepatitis B surface antigen antibody (anti-HBS) administration had no influence on selection pressure in the pre-S region. In contrast, insertions/deletions were more frequently found before OLT. In the 7 patients with deletions/insertions, changes in the hepatocyte attachment site were not seen after OLT. Interestingly, the only patient with changes in a major virus population after OLT had changes in the CCAAT-box of the S-promoter. As shown by gel shift analysis, this mutation was associated with loss of specific binding to this element and thus probably led to dysregulation of S-gene transcription. Major changes in the pre-S genome are mainly seen before OLT, and HBV reinfection does occur with the intact hepatocyte attachment sites after OLT. Anti-HBs (hepatitis B immune globulin [HBIg]) creates no selection pressure on the pre-S region. The mutation in the CCAAT-box of the S-promoter potentially leads to its dysregulation and may be associated with the occurrence of fibrosing cholestatic hepatitis after OLT.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8781311     DOI: 10.1002/hep.510240303

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  12 in total

Review 1.  Treatment of follicular non-Hodgkin's lymphoma.

Authors:  David G Maloney
Journal:  Curr Hematol Rep       Date:  2005-01

Review 2.  Molecular biology of hepatitis B virus: effect of nucleotide substitutions on the clinical features of chronic hepatitis B.

Authors:  Osamu Yokosuka; Makoto Arai
Journal:  Med Mol Morphol       Date:  2006-09       Impact factor: 2.309

3.  The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro.

Authors:  C T Bock; N P Malek; H L Tillmann; M P Manns; C Trautwein
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

4.  Kinetics of phytohemaglutinin-induced IFN-gamma and TNF-alpha expression in peripheral blood mononuclear cells from patients with chronic hepatitis B after liver transplantation.

Authors:  Ying-Mei Tang; Min-Hu Chen; Gui-Hua Chen; Chang-Jie Cai; Xiao-Shun He; Min-Giang Lu; Wei-Min Bao
Journal:  World J Gastroenterol       Date:  2005-08-07       Impact factor: 5.742

5.  Novel F141L pre-S2 mutation in hepatitis B virus increases the risk of hepatocellular carcinoma in patients with chronic genotype C infections.

Authors:  Ho-Suk Mun; Seoung-Ae Lee; Hong Kim; Eung-Soo Hwang; Yoon-Hoh Kook; Bum-Joon Kim
Journal:  J Virol       Date:  2010-10-20       Impact factor: 5.103

6.  A YIDD Mutation in a Case of Recurrent Hepatitis B after Liver Transplantation Induced by an S-escape Mutant.

Authors:  Yun-Jung Oh; Young-Min Park; Sun-Pyo Hong; Soo-Kyeong Shin; Seung-Il Ji; Bo-Hyun Kim; Sang-Jong Park; Zheng Hong
Journal:  Gut Liver       Date:  2010-06-16       Impact factor: 4.519

7.  CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter.

Authors:  F Tacke; C Liedtke; S Bocklage; M P Manns; C Trautwein
Journal:  Gut       Date:  2005-05-04       Impact factor: 23.059

8.  High prevalence of hepatitis B virus pre-s mutant in countries where it is endemic and its relationship with genotype and chronicity.

Authors:  Tran Thien-Tuan Huy; Hiroshi Ushijima; Khin Maung Win; Pairoj Luengrojanakul; Pradeep Krishna Shrestha; Zhao-Hua Zhong; Andrei V Smirnov; Teresa Casanovas Taltavull; Tetsutaro Sata; Kenji Abe
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

Review 9.  Hepatitis B virus mutations related to liver disease progression of Korean patients.

Authors:  Bum-Joon Kim
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 10.  Current prophylactic strategies against hepatitis B virus recurrence after liver transplantation.

Authors:  Li Jiang; Li-Sheng Jiang; Nan-Sheng Cheng; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2009-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.